Literature DB >> 19010270

Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond.

Sandro V Porceddu1, Bryan H Burmeister, Rodney J Hicks.   

Abstract

Positron emission tomography (PET) has emerged as an integral diagnostic tool in the management of head and neck squamous cell carcinoma (HNSCC). This article reviews the usefulness and ongoing dilemmas of fluorine-18 fluorodeoxyglucose (18-F FDG) PET and FDG PET/CT in HNSCC. In addition, it examines the potential role of novel markers and biologic characterization of disease, which in the future may assist in targeted therapeutic strategies.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19010270     DOI： 10.1016/j.hoc.2008.08.009

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  3 in total

Review 1.  The role of FDG PET-CT in the therapeutic evaluation for HNSCC patients.

Authors:  Joji Kawabe; Shigeaki Higashiyama; Atsushi Yoshida; Kohei Kotani; Susumu Shiomi
Journal:  Jpn J Radiol       Date:  2012-04-05       Impact factor: 2.374

2.  Impact of initial FDG PET/CT in the management plan of patients with locally advanced head and neck cancer.

Authors:  F Arias; V Chicata; M J García-Velloso; G Asín; M Uzcanga; C Eito; I Quilez; A Viudez; J Saenz; I Hernández; C Caicedo; M Errasti; M Barrado; F García-Bragado
Journal:  Clin Transl Oncol       Date:  2014-07-31       Impact factor: 3.405

3.  The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: preliminary findings.

Authors:  Munetaka Matoba; Hiroyuki Tuji; Yuzo Shimode; Tamaki Kondo; Kiyotaka Oota; Hisao Tonami
Journal:  Br J Radiol       Date:  2017-01-05       Impact factor: 3.039
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.